Tuberculosis Drug Resistance: A Global Threat

Nachega, Jean B.; Chaisson, Richard E.
January 2003
Clinical Infectious Diseases;1/15/2003 Supplement 1, Vol. 36, pS24
Academic Journal
Resistance to antituberculosis drugs has been a problem since the era of chemotherapy began. After dramatic outbreaks of multidrug-resistant tuberculosis (MDR-TB) in the early 1990s, resistance became recognized as a global problem. MDR-TB now threatens the inhabitants of countries in Europe, Asia, Africa, and the Americas. An understanding of the molecular basis of drug resistance may contribute to the development of new drugs. Management of MDR-TB relies on prompt recognition and treatment with at least 3 drugs to which an isolate is susceptible.


Related Articles

  • Estimating Fitness by Competition Assays between Drug Susceptible and Resistant Mycobacterium tuberculosis of Predominant Lineages in Mumbai, India. Bhatter, Purva; Chatterjee, Anirvan; D'souza, Desiree; Tolani, Monica; Mistry, Nerges // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: Multi Drug Resistant Tuberculosis (MDR TB) is a threat to global tuberculosis control. A significant fitness cost has been associated with DR strains from specific lineages. Evaluation of the influence of the competing drug susceptible strains on fitness of drug resistant strains may...

  • Multidrug resistant tuberculosis in France 1992-4: Two case-control studies. Schwoebel, Valerie; Decludt, Benedicte // BMJ: British Medical Journal (International Edition);09/05/98, Vol. 317 Issue 7159, p630 

    Presents a study on multi resistant turberculosis in France. Statistical information on numerous case studies; Annual prevalence of multidrug resistance; Lack of evidence supporting an epidemic of multidrug resistant tuberculosis.

  • Community based approaches to the control of multidrug resistant tuberculosis: Introducing... Farmer, Paul; Kim, Jim Yong // BMJ: British Medical Journal (International Edition);09/05/98, Vol. 317 Issue 7159, p671 

    Presents information on the control of multidrug resistant tuberculosis. Review of outbreaks which occurred throughout the world; Details on community based strategies designed to enhance local capacity; Information on regions which have suffered outbreaks. INSET: Summary points.

  • XDR gone TOTALLY Resistant? Kemper, Carol A. // Infectious Disease Alert;Feb2012, Vol. 31 Issue 5, p59 

    The article reports that two patients being treated at the Rajiv Ghandi Institute for Chest Disease (RGICD) in Bangalore, India were found to have developed extremely drug resistant version of tuberculosis (XDR-TB) indicating resistance to at least three classes of antimycobacterial drugs.

  • Clinical genomics: TB resistance revealed.  // Nature;7/25/2013, Vol. 499 Issue 7459, p383 

    The article focuses on a research done by Sharon Peacock at the University of Cambridge using whole-genome sequencing of tuberculosis, which found antibiotic resistance in tuberculosis.

  • Improvements needed in infection control, treatment, detection of MDR-TB in China.  // Infectious Disease News;Nov2011, Vol. 24 Issue 11, p14 

    The article deals with the report by officials of the Chinese Center for Disease Control and Prevention (CDC) that most multidrug-resistant tuberculosis cases in China were associated with the Beijing genotype and lower socioeconomic status.

  • Drug-resistant TB.  // New Scientist;5/04/96, Vol. 150 Issue 2028, p10 

    Reports on the occurrence of drug-resistant tuberculosis (TB) in Denmark. Background information on patients; Development of drug-resistant strains of TB in Asia and Africa; Implications.

  • Primary Multidrug-Resistant Tuberculosis--Ivanovo Oblast, Russia, 1999.  // MMWR: Morbidity & Mortality Weekly Report;8/6/1999, Vol. 48 Issue 30, p661 

    Discusses a study on multi-drug resistant tuberculosis (TB) in in the civilian population of Ivanovo, Russia from 1996 to 1998. Information on the TB control strategy of the World Health Organization in Ivanovo which precipitated the study; Methodology of the study; Limitations of the findings...

  • Population-based survey for drug resistance of tuberculosis--Mexico, 1997. Bermudez, R. Acosta; Blanco, P. Acosta; Flores, G. Anzaldo; Campos, S. Balandrano; Rivero, C. Barron; Nava, D. Casteneda; Contreras Ramos, P.; Flisser, A.; Anzaldo, G. Jaime; Morales, P. Kuri; Marquez Fiol, A.R.; Delgado, L. Olivares; Ruiz Matus, C.; Santaella Solis, A.J.; Santos Preciado, J.I.; Soriano Miranda, F.; Tapia Conyer, R.; Zarate Aguilar, A.; Fernandez Garate, I.H.; Rivera, J.A. // JAMA: Journal of the American Medical Association;7/1/98, Vol. 280 Issue 1, p14 

    Reports results of a study in three Mexican states, Baja California, Oaxaca, and Sinaloa, and presents population-based tuberculosis (TB) drug-resistance data. Resistance to first-line treatment drugs, isoniazid, rifampin, and pyrazinamide; The number of patients reporting with acid-fast...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics